• Healthpeak Properties, Inc. has reported past fourth-quarter 2025 sales of US$549.03 million and revenue of US$719.40 million, alongside full-year 2025 revenue of US$2.82 billion and net income of US$71.35 million, and also completed a share repurchase of 5,091,156 shares for US$94.17 million under its July 25, 2024 buyback program.
• The company also issued past earnings guidance for 2026, projecting diluted earnings per common share between US$0.34 and US$0.38, which contrasts with its much lower 2025 diluted EPS from continuing operations of US$0.10 and highlights management’s view of potential earnings improvement.
• With these past results and 2026 EPS guidance, we’ll now examine how Healthpeak’s earnings trajectory shapes its investment narrative.

Find 52 companies with promising cash flow potential yet trading below their fair value.

What Is Healthpeak Properties' Investment Narrative?

For someone considering Healthpeak Properties, the core belief is that a relatively low-margin, capital-intensive healthcare REIT can still offer steady, if uneven, earnings and dividend potential. The latest 2025 results underline that earnings remain volatile, with full-year net income of US$71.35 million and diluted EPS of US$0.10, helped in part by one-off items, while return on equity stays low. Management’s 2026 EPS guidance of US$0.34 to US$0.38 suggests they see room for earnings recovery, but the market’s muted recent price moves hint that investors are still cautious. The completed US$94.17 million buyback, covering only 0.73% of shares, feels more incremental than transformative, so it does not materially shift near term catalysts, which remain earnings quality, interest coverage and execution in core healthcare assets.

However, investors should be aware of how thin interest coverage and low margins constrain flexibility. Despite retreating, Healthpeak Properties' shares might still be trading 46% above their fair value. Discover the potential downside here.

Exploring Other Perspectives

Six fair value views from the Simply Wall St Community span roughly US$14.63 to US$31.42, showing very different expectations. Set this against thin margins and weak interest coverage, and you have plenty of reasons to compare multiple viewpoints before making up your mind.

Explore 6 other fair value estimates on Healthpeak Properties - why the stock might be worth as much as 87% more than the current price!

Build Your Own Healthpeak Properties Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Healthpeak Properties research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Healthpeak Properties research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Healthpeak Properties' overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.
• Outshine the giants: these 27 early-stage AI stocks could fund your retirement.
• Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.